Investors Should Take Note Of Medical Properties Trust Inc (MPW)

Medical Properties Trust Inc (MPW) concluded trading on Wednesday at a closing price of $4.61, with 6.35 million shares of worth about $29.26 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.73% during that period and on Wednesday the price saw a loss of about -1.50%. Currently the company’s common shares owned by public are about 600.60M shares, out of which, 493.28M shares are available for trading.

Stock saw a price change of -6.30% in past 5 days and over the past one month there was a price change of -16.18%. Year-to-date (YTD), MPW shares are showing a performance of 16.71% which decreased to -8.53% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.51 but also hit the highest price of $6.55 during that period. The average intraday trading volume for Medical Properties Trust Inc shares is 10.92 million. The stock is currently trading -7.59% below its 20-day simple moving average (SMA20), while that difference is down -14.15% for SMA50 and it goes to -6.20% lower than SMA200.

Medical Properties Trust Inc (NYSE: MPW) currently have 600.60M outstanding shares and institutions hold larger chunk of about 59.10% of that.

The stock has a current market capitalization of $2.77B and its 3Y-monthly beta is at 1.37. It has posted earnings per share of -$2.76 in the same period. It has a debt-to-equity ratio of 1.99. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MPW, volatility over the week remained 1.72% while standing at 2.59% over the month. Stock’s fiscal year EPS is expected to rise by 100.71% while it is estimated to increase by 494.53% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Exane BNP Paribas on March 12, 2025 offering an Outperform rating for the stock and assigned a target price range of between $5 and $9 to it. Coverage by Colliers Securities stated Medical Properties Trust Inc (MPW) stock as a Buy in their note to investors on September 13, 2024, suggesting a price target of $6.50 for the stock. On July 02, 2024, Exane BNP Paribas Downgrade their recommendations, while on April 17, 2024, Deutsche Bank Upgrade their ratings for the stock with a price target of $5. Stock get a Neutral rating from Colliers Securities on April 10, 2024.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.